DART: Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors
Eligible for screening study DCP 001
Please see http://www.swogstat.org/accrual/dart.htm for up-to-date accrual information and current cohort accrual status (i.e. open, closed, suspended). The website is updated with the most current information daily.
As of today, November 5th, 2019, study S1609 (and all cohorts) is temporarily closed to accrual.